Cargando…
The Geriatric G8 Score Is Associated with Survival Outcomes in Older Patients with Advanced Prostate Cancer in the ADHERE Prospective Study of the Meet-URO Network
Introduction: Androgen receptor pathway inhibitors (ARPIs) have been increasingly offered to older patients with prostate cancer (PC). However, prognostic factors relevant to their outcome with ARPIs are still little investigated. Methods and Materials: The Meet-URO network ADHERE was a prospective...
Autores principales: | Banna, Giuseppe Luigi, Basso, Umberto, Giunta, Emilio Francesco, Fratino, Lucia, Rebuzzi, Sara Elena, Buti, Sebastiano, Maruzzo, Marco, De Giorgi, Ugo, Murianni, Veronica, Cinausero, Marika, Lipari, Helga, Gamba, Teresa, Caffo, Orazio, Bimbatti, Davide, Dri, Arianna, Mosca, Alessandra, Ermacora, Paola, Vignani, Francesca, Msaki, Aichi, Bonifacio, Barbara, Lombardo, Valentina, Conteduca, Vincenza, Fornarini, Giuseppe, Rescigno, Pasquale |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600362/ https://www.ncbi.nlm.nih.gov/pubmed/36290889 http://dx.doi.org/10.3390/curroncol29100612 |
Ejemplares similares
-
Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO Network
por: Rescigno, Pasquale, et al.
Publicado: (2022) -
Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib
por: Rebuzzi, Sara Elena, et al.
Publicado: (2022) -
Impact of Previous Nephrectomy on Clinical Outcome of Metastatic Renal Carcinoma Treated With Immune-Oncology: A Real-World Study on Behalf of Meet-URO Group (MeetUro-7b)
por: Stellato, Marco, et al.
Publicado: (2021) -
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study
por: Rebuzzi, Sara Elena, et al.
Publicado: (2023) -
The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study
por: Rebuzzi, Sara Elena, et al.
Publicado: (2022)